L26/P-132 Perinatal outcomes of Piezo-ICSI versus IVF following vitrified-warmed single blastocyst transfer: a retrospective cohort study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.468 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von K. Hiraoka und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Is Piezo-ICSI associated with comparable perinatal outcomes to IVF following vitrified-warmed single blastocyst transfer, and is it associated with reassuring perinatal safety? Summary answer Piezo-ICSI shows comparable clinical pregnancy, miscarriage, delivery, and complication rates to IVF. However, significantly more female infants were born in the Piezo-ICSI, warranting further investigation. What is known already Piezo-ICSI is increasingly adopted to improve fertilization and oocyte utilization rates by minimizing physical damage to the oolemma. However, concern remains regarding its safety, as limited data exist on its impact on perinatal outcomes, including sex ratio and congenital anomalies, compared to conventional IVF—the benchmark for natural-like fertilization. While studies comparing Piezo-ICSI to conventional ICSI are emerging, large-scale comparisons with IVF are scarce. Establishing the perinatal safety of Piezo-ICSI is crucial for its broader clinical implementation as a primary fertilization technique in assisted reproductive technology. Study design, size, duration This retrospective cohort study was conducted at two centers between June 2016 and August 2023. Multivariable logistic regression adjusting for maternal age and her male partner at oocyte retrieval, BMI, anti-Müllerian hormone level, number of previous oocyte retrieval cycles, embryo transfer cycles, prior deliveries, and prior miscarriages was performed. Participants/materials, setting, methods A retrospective study of 3,605 vitrified-warmed single-blastocyst transfer cycles from 2,223 patients (women <40 years) was conducted. Groups were categorized into IVF (1,732 cycles) and Piezo-ICSI (1,873 cycles). Perinatal outcomes, including pregnancy/miscarriage rates, delivery rates, complications, monozygotic twinning, birth weight, sex ratio, and congenital anomalies, were compared. Statistical significance was assessed using the Mann–Whitney U test, the unpaired Student’s t-test, or Fisher’s exact test, with P < 0.05 considered significant. Main results and the role of chance No significant differences were observed in pregnancy rates (48.4%; 839/1732 vs. 49.4%; 925/1873), miscarriage rates (18.7%; 157/839 vs. 19.8%; 183/925), delivery rates (38.0%; 659/1732 vs. 38.6%; 723/1873), or pregnancy complication rates (21.1%; 139/659 vs. 21.6%; 156/723). A total of 668 infants (from 659 deliveries including 9 monozygotic twins) in the IVF group and 733 infants (from 723 deliveries including 10 monozygotic twins) in the Piezo-ICSI group were born. No significant differences were observed in monozygotic twinning rates (1.3%; 9/668 vs. 1.4%; 10/733), mean birth weight (3024.6 ± 18.2 vs. 3008.5 ± 17.5 g), gestational age (39.04 ± 0.08 vs. 39.00 ± 0.07 weeks), or congenital anomalies rates (2.4% vs. 1.5%). Notably, the Piezo-ICSI group showed a significantly higher proportion of female infants compared to the IVF group (52.5% vs 43.1%; P = 0.0005). The higher proportion of female infants after Piezo-ICSI warrants further investigation and may reflect subtle differences in sperm selection or oocyte activation; however, a chance finding cannot be excluded. Limitations, reasons for caution The retrospective nature of the study and the lack of a direct comparison with conventional ICSI, which was not performed during the study period at the participating centers, are limitations. Additionally, the underlying reasons for the observed difference in sex ratio between IVF and Piezo-ICSI require further investigation. Wider implications of the findings Piezo-ICSI shows comparable pregnancy outcomes to IVF. However, the higher proportion of female births requires further investigation to determine whether this represents a biological effect or a chance finding from multiple comparisons. These findings provide reassurance regarding the perinatal safety of Piezo-ICSI in contemporary single-blastocyst transfer practice. Trial registration number No
Zitieren
APA
Hiraoka, K., Nakajo, H., Kamada, Y., Osugi, M., Watanabe, N., Sujino, T., Nishii, S., & Kawai, K. (2026). L26/P-132 Perinatal outcomes of Piezo-ICSI versus IVF following vitrified-warmed single blastocyst transfer: a retrospective cohort study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.468
Vancouver
Hiraoka K, Nakajo H, Kamada Y, Osugi M, Watanabe N, Sujino T, et al. L26/P-132 Perinatal outcomes of Piezo-ICSI versus IVF following vitrified-warmed single blastocyst transfer: a retrospective cohort study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.468
BibTeX
@article{Hiraoka2026,
author = {Hiraoka, K. and Nakajo, H. and Kamada, Y. and Osugi, M. and Watanabe, N. and Sujino, T. and Nishii, S. and Kawai, K.},
title = {L26/P-132 Perinatal outcomes of Piezo-ICSI versus IVF following vitrified-warmed single blastocyst transfer: a retrospective cohort study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.468}
}
EUVIMED